Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2025) 110 EP1456 | DOI: 10.1530/endoabs.110.EP1456

1Zuyderland Medical Center, Internal Medicine, Heerlen/Sittard-Geleen, Netherlands; 2Zuyderland Medical Center, Surgery, Sittard-Geleen, Netherlands; 3Erasmus Medical Center, Internal Medicine, Rotterdam, Netherlands.


JOINT1445

Background: Hypocalcemia is a common complication of thyroidectomy, often necessitating hospitalization for calcium supplementation. Previous studies yielded contradictory results on whether cholecalciferol prevents postoperative hypocalcemia, and most were conducted in non-Western countries with different dietary habits and baseline vitamin D levels. Therefore, we aimed to investigate the effect of preoperative cholecalciferol on post-thyroidectomy hypocalcemia in a Dutch population.

Methods: Patients who underwent thyroidectomy between 2023-2025 received 100,000 IU cholecalciferol one week preoperative (‘vitamin D group’) and were compared to a historical cohort (2019-2022) who did not receive cholecalciferol supplementation (‘control group’). Outcomes included incidence of post-thyroidectomy hypocalcemia (<2.00 mmol/l, 24h,48h,72h,>72h postoperative), need for postoperative supplementation, time until normocalcemia, length of hospital stay, and hospital readmission.

Results: Fifty patients received preoperative cholecalciferol and were compared to 154 control patients (82.8% female, median age: 55 years [IQR:43-66]). Hypocalcemia occurred less frequently in the vitamin D group (cumulative incidence: 16.0% vs. 35.1%, P = 0.01 for biochemical and 12.0% vs. 24.0%, P = 0.07 for symptomatic hypocalcemia). Preoperative cholecalciferol supplementation was associated with a reduced risk of hypocalcemia (OR 0.27,95%CI:0.11-0.68, P = 0.005). Furthermore, the vitamin D group demonstrated a lower need for postoperative supplementation (32.0% vs. 53.9%, P = 0.007) and faster recovery to normocalcemia (0[0-2] vs. 3[0-11] days, P = 0.002). No differences were observed in length of hospital stay and hospital readmissions.

Conclusion: A preoperative dose of 100,000 IU cholecalciferol was associated with a significant reduction in post-thyroidectomy hypocalcemia. With a number needed to treat of 5 patients to prevent one case of hypocalcemia, this inexpensive and safe intervention could be considered for routine use in patients undergoing thyroidectomy.

Volume 110

Joint Congress of the European Society for Paediatric Endocrinology (ESPE) and the European Society of Endocrinology (ESE) 2025: Connecting Endocrinology Across the Life Course

European Society of Endocrinology 
European Society for Paediatric Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches